Back
Nuveen CA Select Tax Free Income Port Vs. Viking Therapeutics Industry Stock Comparison
Sell
36
NXC
Nuveen CA Select Tax Free Income Port
Last Price:
13.96
Seasonality Move:
-2.11%
Buy
82
VKTX
Viking Therapeutics
Last Price:
62.98
Seasonality Move:
18.2%
Sell
36
Nuveen CA Select Tax Free Income Port (NXC)
is a Sell
Is Nuveen CA Select Tax Free Income Port a Buy, Sell or Hold?
- The current Nuveen CA Select Tax Free Income Port [NXC] share price is $13.82. The Score for NXC is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- NXC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $67.10. The Score for VKTX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NXC Stock Price Chart
What is Nuveen CA Select Tax Free Income Port's stock price today?
-
The Nuveen CA Select Tax Free Income Port share price today is $13.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NXC is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $67.10
The current trend is moderately bullish and VKTX is experiencing slight buying pressure.
NXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 54.36 | Buy |
| Chaikin Money Flow: | -12210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.66 - 13.88) | Buy |
| Bollinger Bands (100): | (13.01 - 13.69) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.2 | Buy |
| Relative Strength Index (14 RSI): | 62.61 | Buy |
| Chaikin Money Flow: | 567314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.61 - 65.05) | Buy |
| Bollinger Bands (100): | (51.89 - 68.87) | Buy |
NXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.89 | Sell |
| 20-day SMA: | 13.78 | Buy |
| 50-day SMA: | 13.58 | Buy |
| 200-day SMA: | 13.2 | Buy |
| 8-day EMA: | 13.86 | Sell |
| 20-day EMA: | 13.79 | Buy |
| 50-day EMA: | 13.61 | Buy |
| 200-day EMA: | 13.28 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.56 | Buy |
| 20-day SMA: | 61.72 | Buy |
| 50-day SMA: | 58.06 | Buy |
| 200-day SMA: | 51.71 | Buy |
| 8-day EMA: | 62.12 | Buy |
| 20-day EMA: | 60.56 | Buy |
| 50-day EMA: | 59.23 | Buy |
| 200-day EMA: | 50.85 | Buy |
Nuveen CA Select Tax Free Income Port Earnings Growth & NXC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Nuveen CA Select Tax Free Income Port Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||